Evidence map›Paper›PMID 38698856›Full record

ArticleFrontiers in immunology2024

Mapping the interaction sites of human and avian influenza A viruses and complement factor H.

Iman Rabeeah, Elizabeth Billington, Béatrice Nal, Jean-Remy Sadeyen, Ansar A Pathan, Munir Iqbal, Nigel J Temperton, Peter F Zipfel, Christine Skerka, Uday Kishore and 1 more

Abstract read
In one paragraph

Article in Frontiers in immunology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Iman RabeeahPirbright Institute, Woking, United Kingdom.
Elizabeth BillingtonPirbright Institute, Woking, United Kingdom.
Béatrice NalAix-Marseille Université, CNRS, INSERM, CIML, Marseille, France.
Jean-Remy SadeyenPirbright Institute, Woking, United Kingdom.
Ansar A PathanBiosciences, College of Health, Medicine and Life Sciences, Brunel University London, Uxbridge, United Kingdom.
Munir IqbalPirbright Institute, Woking, United Kingdom.
Nigel J TempertonViral Pseudotype Unit, University of Kent, Chatham, United Kingdom.
Peter F ZipfelDepartment of Infection Biology, Leibniz Institute for Natural Product Research and Infection Biology, Jena, Germany.
Christine SkerkaDepartment of Infection Biology, Leibniz Institute for Natural Product Research and Infection Biology, Jena, Germany.
Uday KishoreDepartment of Veterinary Medicine, United Arab Emirates University, Al Ain, United Arab Emirates.
Holly SheltonPirbright Institute, Woking, United Kingdom.

Funding

Biotechnology and Biological Sciences Research Council BBS/E/I/00007034Biotechnology and Biological Sciences Research Council BBS/E/I/00007038
6 · The paper itself

Abstract

The complement system is an innate immune mechanism against microbial infections. It involves a cascade of effector molecules that is activated via classical, lectin and alternative pathways. Consequently, many pathogens bind to or incorporate in their structures host negative regulators of the complement pathways as an evasion mechanism. Factor H (FH) is a negative regulator of the complement alternative pathway that protects "self" cells of the host from non-specific complement attack. FH has been shown to bind viruses including human influenza A viruses (IAVs). In addition to its involvement in the regulation of complement activation, FH has also been shown to perform a range of functions on its own including its direct interaction with pathogens. Here, we show that human FH can bind directly to IAVs of both human and avian origin, and the interaction is mediated via the IAV surface glycoprotein haemagglutinin (HA). HA bound to common pathogen binding footprints on the FH structure, complement control protein modules, CCP 5-7 and CCP 15-20. The FH binding to H1 and H3 showed that the interaction overlapped with the receptor binding site of both HAs, but the footprint was more extensive for the H3 HA than the H1 HA. The HA - FH interaction impeded the initial entry of H1N1 and H3N2 IAV strains but its impact on viral multicycle replication in human lung cells was strain-specific. The H3N2 virus binding to cells was significantly inhibited by preincubation with FH, whereas there was no alteration in replicative rate and progeny virus release for human H1N1, or avian H9N2 and H5N3 IAV strains. We have mapped the interaction between FH and IAV, the

Indexed as

Complement Factor HHemagglutinin Glycoproteins, Influenza VirusInfluenza A virusInfluenza, HumanProtein BindingAnimalsBinding SitesBirdsHost-Pathogen InteractionsHumansInfluenza A Virus, H3N2 SubtypeInfluenza A Virus, H9N2 SubtypeInfluenza in BirdsCFH protein, humanComplement Factor HHemagglutinin Glycoproteins, Influenza Virusavian influenzacomplemententry inhibitorfactor Hhuman influenzainfluenza A viruspseudotype

Identifiers

PMID38698856
PMCPMC11064062

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.